US Congress faces unfinished healthcare business
This article was originally published in Clinica
Executive Summary
Returning from its month-long August recess, the US Congress faces a mountain of unfinished healthcare business, including major legislation on patents, user fees and government health programmes impacting medical device policy, writes April Fulton.